- All sections
- C - Chemistry; metallurgy
- C07H - Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids
- C07H 19/173 - Purine radicals with 2-deoxyribosyl as the saccharide radical
Patent holdings for IPC class C07H 19/173
Total number of patents in this class: 254
10-year publication summary
|
15
|
19
|
17
|
11
|
16
|
18
|
14
|
16
|
10
|
10
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1918 |
13 |
| Agilent Technologies, Inc. | 2721 |
10 |
| Nucana plc | 85 |
8 |
| Merck Sharp & Dohme LLC | 3715 |
8 |
| Alnylam Pharmaceuticals, Inc. | 1099 |
7 |
| Illumina Cambridge Limited | 681 |
7 |
| ViiV Healthcare Company | 149 |
6 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 271 |
5 |
| Alios BioPharma, Inc. | 67 |
5 |
| Janssen Biopharma, Inc. | 48 |
5 |
| Ajinomoto Co., Inc. | 2329 |
4 |
| CARIS Science, Inc. | 65 |
4 |
| The Scripps Research Institute | 1356 |
4 |
| Merck Sharp & Dohme Corp. | 2226 |
3 |
| Janssen Pharmaceuticals, Inc. | 407 |
3 |
| Massachusetts Institute of Technology | 9837 |
3 |
| Yamaha Corporation | 4031 |
3 |
| Idenix Pharmaceuticals LLC | 64 |
3 |
| Ionis Pharmaceuticals, Inc. | 798 |
3 |
| Isis Pharmaceuticals, Inc. | 236 |
3 |
| Other owners | 147 |